Acute Mesenteric Ischemia — Recognition and Management

Key Points

• Severe abdominal pain with a relatively benign early examination should raise concern but is not required for the diagnosis.
• CTA should be obtained without delay when acute mesenteric ischemia is suspected; a normal lactate does not exclude early disease.
• Mechanism matters: arterial embolism, arterial thrombosis, nonocclusive ischemia, and venous thrombosis require different definitive strategies.
• Broad-spectrum antibiotics are started early because ischemic bowel loses mucosal barrier function.
• Therapeutic anticoagulation is central to mesenteric venous thrombosis and is frequently used in arterial disease when not contraindicated.
• Peritonitis indicates likely bowel necrosis and requires urgent operative exploration.
• Revascularization should be achieved as early as possible when salvageable bowel is threatened.
• Second-look surgery is often valuable when bowel viability is uncertain after revascularization.

Algorithm

1. Suspect the diagnosis in severe, unexplained, or rapidly progressive abdominal pain in a patient with vascular, embolic, low-flow, or thrombotic risk.
2. Assess hemodynamics and peritoneal signs while obtaining CBC, chemistries, lactate, coagulation studies, and type and screen.
3. Obtain multiphase CT angiography of the abdomen and pelvis promptly; do not wait for lactate to rise.
4. Begin IV resuscitation, broad-spectrum antibiotics, analgesia, and early surgical plus vascular or interventional consultation.
5. Start unfractionated heparin when appropriate and not contraindicated, especially for mesenteric venous thrombosis.
6. If peritonitis, perforation, or clear transmural necrosis is present, proceed urgently to operative exploration.
7. For arterial occlusion with potentially salvageable bowel, perform rapid endovascular, open, or hybrid revascularization according to anatomy and expertise.
8. For mesenteric venous thrombosis without peritonitis, continue anticoagulation and close serial examination.
9. For nonocclusive ischemia, correct the low-flow state and minimize avoidable vasoconstriction; consider catheter-directed vasodilator therapy in selected cases.
10. Reassess bowel viability after reperfusion and use planned second-look surgery when viability remains uncertain.

Clinical Synopsis & Reasoning

Acute mesenteric ischemia is abrupt impairment of intestinal blood flow caused by arterial embolism, arterial thrombosis, nonocclusive mesenteric ischemia, or mesenteric venous thrombosis. Early disease can produce severe visceral pain with relatively little abdominal tenderness because mucosal and muscular ischemia precede transmural necrosis and peritonitis. The classic description of pain out of proportion to examination is useful but not sufficiently sensitive to rule disease in or out. As infarction progresses, guarding, rebound, ileus, sepsis, shock, and gastrointestinal bleeding may appear.

Risk factors help define the likely mechanism. Arterial embolism is associated with atrial fibrillation, recent myocardial infarction, valvular disease, ventricular thrombus, and embolic events elsewhere. In-situ arterial thrombosis usually occurs on chronic mesenteric atherosclerosis and may be preceded by postprandial pain, food fear, and weight loss. Nonocclusive mesenteric ischemia occurs in low-flow or intense vasoconstrictive states such as cardiogenic shock, septic shock, severe heart failure, dialysis-associated hypotension, or high-dose vasopressor exposure. Mesenteric venous thrombosis is associated with malignancy, inflammatory bowel disease, intra-abdominal infection, pancreatitis, portal hypertension, inherited or acquired thrombophilia, and estrogen exposure, although some cases remain idiopathic.

No laboratory test can exclude acute mesenteric ischemia. Leukocytosis, metabolic acidosis, elevated lactate, hemoconcentration, and D-dimer abnormalities may occur, but lactate can be normal early and can rise from many nonintestinal causes. A normal lactate must never delay imaging when clinical suspicion is meaningful. CT angiography of the abdomen and pelvis is the key diagnostic test and should be performed promptly, including in many patients with renal dysfunction because the harm from delayed bowel diagnosis generally exceeds the contrast-associated risk. CTA can identify arterial occlusion, venous thrombosis, bowel wall changes, pneumatosis, portal venous gas, and alternative abdominal emergencies.

Treatment Strategy & Disposition

Begin treatment while imaging and surgical consultation are being arranged. Establish IV access, correct hypovolemia with balanced resuscitation, treat shock, correct major electrolyte and acid-base abnormalities, and avoid unnecessary vasoconstrictor escalation when alternative methods can maintain perfusion. Administer broad-spectrum antibiotics early because loss of mucosal integrity promotes bacterial translocation. Nasogastric decompression is useful when ileus or vomiting is prominent. Unfractionated heparin is commonly started in acute mesenteric ischemia when there is no contraindication, particularly in mesenteric venous thrombosis and many arterial occlusive presentations, because it limits thrombus propagation and is rapidly reversible if surgery is needed.

Peritonitis or imaging strongly suggesting transmural necrosis requires immediate operative exploration. The priorities are revascularization when feasible, assessment of the entire bowel, resection of clearly nonviable segments, and preservation of bowel length. When bowel viability is uncertain after revascularization and resuscitation, damage-control surgery with planned second-look laparotomy is often preferable to aggressive initial resection. Short-bowel syndrome is a major long-term consequence of extensive infarction.

In arterial occlusion without established peritonitis, an endovascular-first or hybrid strategy is increasingly used when expertise is available. Options include aspiration or mechanical thrombectomy, catheter-directed interventions, angioplasty, stenting, and open embolectomy or bypass depending on anatomy and mechanism. Revascularization should not be delayed when bowel is threatened. Mesenteric venous thrombosis without peritonitis is usually treated initially with therapeutic anticoagulation and close observation rather than immediate surgery. Nonocclusive mesenteric ischemia requires correction of the underlying low-flow state, optimization of cardiac output and volume, reduction of excessive vasoconstrictor exposure when possible, and in selected centers intra-arterial vasodilator therapy. All patients with suspected acute mesenteric ischemia require early surgical and vascular or endovascular involvement.

Epidemiology / Risk Factors

• Acute mesenteric ischemia is uncommon but has high mortality because early symptoms can be nonspecific and bowel infarction can evolve quickly.
• Arterial embolism has historically been a leading mechanism, often related to atrial fibrillation.
• Atherosclerotic mesenteric arterial thrombosis is more common in patients with established peripheral, coronary, or cerebrovascular disease.
• Nonocclusive mesenteric ischemia occurs mainly in critically ill patients with low-flow states and can be difficult to recognize because they may be sedated or ventilated.
• Mesenteric venous thrombosis represents a smaller but important subset and generally has a more favorable prognosis when diagnosed before infarction.
• Older age and cardiovascular comorbidity increase incidence, but venous thrombosis can occur in younger patients with thrombophilia or inflammatory disease.

Investigations

Key Differentials

Pharmacology

Prognosis / Complications

• Mortality rises sharply once transmural bowel necrosis, sepsis, or multiorgan failure develops.
• Time to diagnosis and restoration of mesenteric perfusion is one of the most important modifiable determinants of outcome.
• Mesenteric venous thrombosis diagnosed before peritonitis often has better outcomes with anticoagulation alone.
• Extensive resection can lead to short-bowel syndrome and long-term dependence on specialized nutrition or intestinal rehabilitation.
• Recurrent arterial events depend on control of embolic or atherosclerotic risk, including anticoagulation for atrial fibrillation when indicated.
• Survivors require follow-up for nutritional status, vascular disease, anticoagulation management, and recurrent postprandial symptoms.

Patient Education / Counseling

• Explain that sudden severe abdominal pain in a patient with prior mesenteric ischemia or vascular disease requires immediate reassessment.
• Patients with atrial fibrillation should understand the importance of prescribed anticoagulation when indicated.
• After arterial disease, address smoking, lipids, diabetes, blood pressure, and antiplatelet therapy according to the vascular plan.
• After mesenteric venous thrombosis, review anticoagulation duration, bleeding precautions, and whether thrombophilia or malignancy evaluation is needed.
• Patients who undergo bowel resection may need dietitian support, monitoring for malabsorption, and specialized intestinal rehabilitation.
• Return urgently for recurrent abdominal pain, gastrointestinal bleeding, persistent vomiting, fever, or inability to tolerate food.

Notes

The central diagnostic principle is that no biomarker is sensitive enough to safely rule out acute mesenteric ischemia. Lactate may be normal before advanced ischemia and should be treated as a severity and trajectory marker rather than a screening gate. When clinical suspicion is substantial, CTA is the decisive early study.

The 2022 World Society of Emergency Surgery guideline emphasizes prompt CTA, early resuscitation, broad-spectrum antibiotics, and rapid revascularization when arterial occlusion threatens viable bowel. The same guideline supports anticoagulation as first-line therapy for mesenteric venous thrombosis when there is no peritonitis and highlights correction of the precipitating low-flow state in nonocclusive disease.

Clinical deterioration after apparently reassuring early findings should trigger immediate reassessment. The transition from mucosal ischemia to transmural necrosis can be rapid, and peritoneal signs are a late finding. The best opportunity to preserve bowel is before that transition occurs.

References

1. World Society of Emergency Surgery 2022 Updated Guidelines for Acute Mesenteric Ischemia — Link